Society for Maternal-Fetal Medicine Position Statement: Prioritizing and Investing in Pregnancy Research
SMFM2020
SMFM — 2020
To effectively address maternal mortality, severe maternal morbidity, and to make progress toward health equity for pregnant women and women at risk of pregnancy complications and mortality, it is critical that the federal government, industry, and philanthropic foundations prioritize investment in and expansion of research and clinical trials in pregnancy. Improving a woman’s health before, during, and after pregnancy has the potential to benefit women, the developing child, and families through subsequent generations.
The Society for Maternal-Fetal Medicine (SMFM) urges the United States Congress to prioritize and invest specific resources for research in pregnant women, including additional funding to study, evaluate, disseminate, and implement interventions that optimize pregnancy outcomes. We also encourage industry and private funders to increase support for pregnancy-related research and work collaboratively with other stakeholders to optimize the health of women during pregnancy. Such research efforts are required in order to drive meaningful change in clinical practice, to provide an evidence base for practice, and to improve maternal and pregnancy related health outcomes.
To effectively address maternal mortality, severe maternal morbidity, and to make progress toward health equity for pregnant women and women at risk of pregnancy complications and mortality, it is critical that the federal government, industry, and philanthropic foundations prioritize investment in and expansion of research and clinical trials in pregnancy. Improving a woman’s health before, during, and after pregnancy has the potential to benefit women, the developing child, and families through subsequent generations.
The Society for Maternal-Fetal Medicine (SMFM) urges the United States Congress to prioritize and invest specific resources for research in pregnant women, including additional funding to study, evaluate, disseminate, and implement interventions that optimize pregnancy outcomes. We also encourage industry and private funders to increase support for pregnancy-related research and work collaboratively with other stakeholders to optimize the health of women during pregnancy. Such research efforts are required in order to drive meaningful change in clinical practice, to provide an evidence base for practice, and to improve maternal and pregnancy related health outcomes.